Management of abruptio placentae.
D000037:Abruptio Placentae / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D000328:Adult; D000347:Afibrinogenemia / Q000150:complications; D000650:Amnion / Q000601:surgery; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D002585:Cesarean Section; D036861:Delivery, Obstetric; D003937:Diagnosis, Differential; D005260:Female; D005313:Fetal Death / Q000209:etiology; D006400:Hematocrit; D006470:Hemorrhage / Q000175:diagnosis; D006801:Humans; D007751:Labor, Induced; D008423:Maternal Age; D010121:Oxytocin / Q000627:therapeutic use; D010298:Parity; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis; D011644:Puerperal Disorders; D013997:Time Factors
D000933:Antifibrinolytic Agents; D010121:Oxytocin